Lucara Diamond Corp. ("Lucara" or the "Company") is pleased to announce the results of an updated technical report (the "Report") for the updated Feasibility Study ("FS" or "Study"), prepared in ...
VANCOUVER, BC, Jan. 5, 2026 /PRNewswire/ -- (TSX: LUC) (BSE: LUC) (Nasdaq First North: LUC) Lucara Diamond Corp. ("Lucara" or the "Company") is pleased to announce the results of an updated ...
GSK has received approval from China’s National Medical Products Administration for Nucala as an add-on maintenance therapy for adults with inadequately controlled COPD and elevated blood eosinophils.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback